The promise of AI in healthcare has always been efficiency: faster diagnoses, fewer errors, smarter resource allocation. But the country’s largest health insurers are now pushing back on that narrative with a pointed counterargument — AI is already making healthcare more expensive, and the bills are landing on their desks. According to a TechCrunch report, major insurers are flagging AI-assisted diagnostic and treatment tools as a direct driver of rising claims costs, a development that could reshape how the industry regulates and reimburses the technology. The tension here is real, and it connects to broader questions Future Wire has been tracking about AI agents operating inside healthcare systems with limited oversight.
Insurers argue the mechanism is straightforward: AI tools surfacing more potential diagnoses and flagging more conditions for follow-up means more tests ordered, more specialists consulted, and more procedures approved. Each individual recommendation may be clinically defensible, but in aggregate, the volume effect is driving costs up across the board. This is not a theoretical concern about the future — insurers say they are observing it in current claims data.
Diagnosis Creep and the Volume Problem
The core issue is what critics are calling AI-enabled diagnosis creep. When a machine learning model is trained to detect anomalies, it will find anomalies — including ones a human clinician might have reasonably deprioritized or monitored rather than treated aggressively. For insurers, that translates directly into claim volume. A system that catches 20 percent more borderline cases does not simply improve outcomes; it also generates 20 percent more referrals, imaging orders, and specialist visits that all need to be paid for.
Providers and AI developers counter that identifying more conditions earlier is precisely the point — that catching a cancer at stage one instead of stage three saves money downstream. But insurers dispute that the math is working out that way in practice, at least not yet. They contend the near-term cost spike is real and measurable, while the long-term savings remain speculative and unevenly distributed across payer and provider systems that do not share financial risk symmetrically.
Who Bears the Cost — and Who Controls the Tools
One of the sharpest fault lines in this debate is the question of who controls the AI systems generating these recommendations. In most cases, it is the provider — a hospital, a clinic, a diagnostics company — deploying AI tools that were approved by regulators and adopted to improve care quality. Insurers, by contrast, sit downstream and absorb the financial output of those decisions without having meaningful input into how the tools are calibrated or what thresholds trigger a recommendation.
That asymmetry is starting to generate serious friction. Some insurers are reportedly pushing for greater transparency into the AI models driving clinical decisions, arguing that if an algorithm is effectively setting the scope of care, payers need visibility into how it works. This mirrors tensions playing out in AI agent deployment across other industries, where accountability gaps between developers, deployers, and end users are creating disputes over who owns the outcome. Separately, reporting from Business Insider on AI agents in customer service contexts highlights a parallel pattern: companies adopting AI-driven workflows often underestimate the downstream volume effects until cost signals force a reckoning.
The stakes extend well beyond corporate margin disputes. If AI does structurally inflate healthcare utilization, that pressure will eventually reach patients through higher premiums, tighter prior authorization rules, or benefit redesigns that restrict access to the very AI-assisted care the technology was supposed to democratize. Regulators are only beginning to grapple with how to handle AI tools that are simultaneously FDA-cleared medical devices and active cost drivers — a category that existing frameworks were not built to manage. The insurers raising the alarm now may be the first to force that conversation into the open.
